Passage Bio, Inc. (PASG) Reports In-Line Q1 EPS

Passage Bio, Inc. (NASDAQ: PASG) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold
• Morgan Stanley Upgrades Coal India Ltd (COAL:IN) to Overweight